India’s Cipla: ‘Huge wave’ of pandemic-driven interest in health and wellness
CNBC International’s Tanvir Gill and Nancy Hungerford interact with Umang Vohra to discuss the company’s performance, play in COVID-19 and future outlook and plans. Umang talks about how only 5% of the company’s sales come from Remdesivir and the COVID related portfolio, and that the company is also doing incredibly well beyond the COVID portfolio. The conversation highlights how Cipla is the No. 2 seller of respiratory devices across the world and is seeing very strong momentum in the lung therapy as lung leaders of the world, as well as in other therapies.
Source credit: Interview appeared on CNBC International's Street Signs Asia show
Cipla stands strong with India in the battle against COVID-19
News: Cipla announced a INR 25 crore fund to support the Indian Government’s efforts to effectively combat the COVID-19 pandemic. This includes a voluntary donation of approximately INR 3 crore from Cipla employees who have stepped forward in this hour of national need. Through its wide-ranging relief efforts, the Company is focusing on initiatives that have the maximum impact and reach. It is currently supporting public health institutions, frontline healthcare workers, vulnerable patients and communities struggling in the aftermath.
Coronavirus drug in 6 months after producing API
News: Mumbai-based drug major Cipla, credited with several innovations especially in respiratory and flu therapy, could well become one of the first domestic companies to roll out new drugs for the coronavirus. The company is both fast-tracking development of these drugs with government laboratories, and repurposing its wide portfolio of respiratory, asthma, anti-virals and HIV drugs to meet challenges arising from Covid-19 in India.
Cipla: Breath of new air
Structural changes in the global pharma industry are throwing up challenges and opportunities. Enter Cipla with its expertise in medicine, and vision for relevance beyond pharma.
Therapies at Cipla
With our growing scientific understanding of rare diseases, we shall continue to introduce ground breaking therapies to give our patients their new beginnings!
Hear it from the Cipla-ites!
Working at Cipla has always been an exciting journey full of learning. I always felt encouraged to take initiatives and to think out of the box. I don't remember spending 2 identical days during my 5 years journey at Cipla - and even now, the work at Cipla continues to be as exciting as on day 1! The entrepreneurial culture within the company pushes us all to take risks and think creatively.
“8 weeks, 4 projects, 2 new countries and an amazing experience. I am happy to have taken the baby steps in my management career at Cipla. I was overwhelmed by the trust that my project guide and owner put in me. I am thankful to Cipla for giving me the opportunity to spend my summer as an intern here.”
“Cipla is a 83-year old start-up. We are in midst of a very exciting transformation journey at Cipla and every day is a unique challenge: working on multiple game changing projects in HR to solve the toughest problems, keeps us on our toes all the time. One year in Cipla has been a roller coaster ride: my role has changed three times in a year and the excitement continues!”
“For me, Cipla is a land of opportunities. Over last 3.5 years of being with the Company, I have worked across 4 very different roles - from Business Finance to M&A to now leading the Global CFO’s Office and Investor Relations for the Company. I believe that at Cipla, it is potential which matters more than experience.”
Stock Price Index
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2020
07th August 2020
With Cipla Foundation, we envision and execute Cipla’s Corporate Social Responsibility. In the last year, we have reached out to over 2,20,000 individuals in the community across in Health, Education, Skilling and Disaster Response.
Support replicable and scalable models towards sustainable change.
Generate evidence, knowledge and skilled workforce in our chosen domains.
Support to communities affected by disasters.
Sparking the curiosity for learning.